Ticker

Analyst Price Targets — APYX

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
March 11, 2026 1:12 pmCraig-Hallum$6.00$3.93TheFly Apyx Medical price target raised to $6 from $5 at Craig-Hallum
December 15, 2025 9:05 pmRoth Capital$6.00$3.82TheFly Apyx Medical initiated with a Buy at Roth Capital
December 8, 2022 9:02 amLake Street$5.00$1.85Benzinga Lake Street Assumes Apyx Medical at Buy, Announces Price Target of $5
August 11, 2022 8:54 pmMatt O'BrienPiper Sandler$12.00$10.28TheFly Apyx Medical price target raised to $12 from $6 at Piper Sandler
July 19, 2022 10:29 amLake Street$17.00$8.44Benzinga Lake Street Maintains Buy on Apyx Medical, Raises Price Target to $17

Latest News for APYX

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

CLEARWATER, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its fourth quarter and full year ended December 31, 2025.

GlobeNewsWire • Mar 10, 2026
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference

CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that management will participate in The Citizens Life Sciences Conference on Wednesday, March 11, 2026, in Miami, FL.

GlobeNewsWire • Feb 18, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for APYX.

No House trades found for APYX.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top